Results 131 to 140 of about 15,495 (203)

MFSD12, transcriptionally regulated by PLAGL2, promotes bladder cancer progression

Communications Biology
Bladder cancer (BLCA) is one of the most common malignant tumors of the urinary system. Identification of novel molecular signaling targets for the tumorigenesis of BLCA is important.
Jiani He, Changming Dong, Xiandong Song, Xinyu Bao, Zhongkai Qiu, Hao Zhang, Yuanjun Jiang, Tao Liu, Xiaojun Man   +8 more
doaj   +1 more source

Performance of 18F-FDG PET/MRI and its parameters in staging and neoadjuvant therapy response evaluation in bladder cancer

iScience
Summary: 18F-FDG PET/MRI shows potential efficacy in the diagnosis of bladder cancer (BLCA). However, the performance of 18F-FDG PET/MRI in staging and neoadjuvant therapy (NAT) response evaluation for BLCA patients remains elusive. Here, we conduct this
Tianhang Li, Qinqin You, Shiwei Zhang, Rushuai Li, Shangxun Xie, Danyan Li, Shuyue Ai, Rong Yang, Hongqian Guo   +8 more
doaj   +1 more source

260: BLCA-4, A Highly Specific Marker Urine-Based Markerof Bladder Cancer [PDF]

Journal of Urology, 2004
Thu-Suong Van Le, Raymond Miller, Timothy Barder, Marko Babjuk, Douglas M. Potter, Robert H. Getzenberg   +5 more
openaire   +1 more source

Interpreting pathways to discover cancer driver genes with Moonlight [PDF]

, 2020
al., et, Bailey, Matthew H., Colaprico, Antonio   +2 more
core   +1 more source

Multi-omics identification of a programmed cell death-related signature and potential target P4HB for bladder cancer based on a 101-combination machine learning and experimental validation. [PDF]

Clin Exp Med
Cao Y, Li C, Hua Y, Wu T, Shen Q, Lin Z, Huang Y.   +6 more
europepmc   +1 more source

Influencing Factors and Risk Prediction Model Construction of Urinary Tract Infections in Patients with Bladder Cancer

Research and Reports in Urology
Yancheng Di, Lingling Zhang, Linlin Zhao, Lei Yin Department of Urology, Hongqi Hospital Affiliated to Mudanjiang Medical University, Mudanjiang, 157000, People’s Republic of ChinaCorrespondence: Lei Yin, Department of Urology, Hongqi Hospital Affiliated
Di Y, Zhang L, Zhao L, Yin L
doaj  

TNFRSF17 as a complementary biomarker to PD-L1 for predicting the response to immunotherapy in urothelial bladder cancer. [PDF]

PLoS One
Chen J, Li B, Gan Y, Li P.
europepmc   +1 more source

Leveraging untargeted metabolomics in combination with machine learning to uncover novel insights into bladder cancer. [PDF]

Cancer Metab
Kamal AHM, Putluri V, Gandhi T, Ambati CSR, Amara CS, Kami Reddy KR, Spradlin ML, Koirala A, Jorvekar SB, Grimm SL, Fu D, Parsawar K, Jong F, Beecher C, Sen S, Lerner SP, Siddiqui MM, Lotan Y, Eberlin LS, Sreekumar A, Coarfa C, Putluri N.   +21 more
europepmc   +1 more source

Dysregulated Peroxiredoxins in Bladder Cancer Are Associated With an Altered Tumour Immune Microenvironment. [PDF]

J Cell Mol Med
Wallerson J, Rostampour S, Teng S, Kidane D.   +3 more
europepmc   +1 more source

Hypoxia-Induced TGFBI Promotes Bladder Cancer Progression by Creating a Stemness Regulation Loop through Stabilizing the Disulfide Bonds of GDF15. [PDF]

Research (Wash D C)
Zhang G, Wang L, Zhao G, Huang Y, Yu J, Cao Y, Sun R, Li Q, Wei Z, Jiang Y, Peng Y, He W, Xie Y, Liu J.   +13 more
europepmc   +1 more source